ANZCA points to a UK study of 47,000 patients finding GLP-1 users had 11 times the risk of regurgitation or aspiration under general anaesthetic.
Recap by typeshit. Full story at RNZ.
An older explainer sorting the weight loss market into approved medications, telehealth compounded drugs, online gray market peptides and supplements.
The FDA had warned the Cary, North Carolina pharmacy in December 2025 about sterile production problems. Check your vial's lot number and beyond-use date.
Reuters looks at influencers pushing dietary supplements to people on weight loss drugs, turning TikTok into a sales engine for so-called GLP-1 products.
In her second month on the drug, she says the scale hasn't moved since stepping up to 5 mg and an itch has spread over her body. She asks others if they've had the same.
A short clip looks back at Canadian scientist Daniel Drucker and his early research at Harvard that helped lay the groundwork for today's GLP-1 medicines.
A Roomba and a smoke detector join the cast of the 30-second spot, the latest in Noom's Lose for Keeps campaign starring Rebel Wilson as its wellness ambassador.
Loading…